Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank53
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-9.77M
↑ 71% vs avg
Percentile
P53
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-33.43M
Historical baseline
PeriodValueYoY Change
TTM$-9.77M+45.4%
2024$-17.88M+3.7%
2023$-18.56M+52.2%
2022$-38.83M-173.0%
2021$-14.22M-48.4%
2020$-9.59M+80.2%
2019$-48.41M+23.1%
2018$-62.92M-661.6%
2017$-8.26M+92.2%
2016$-105.82M-